Literature DB >> 25754386

Partial vs radical nephrectomy for T1 renal tumours: an analysis from the British Association of Urological Surgeons Nephrectomy Audit.

Marios Hadjipavlou1, Fahd Khan1, Sarah Fowler2, Adrian Joyce3, Francis X Keeley4, Seshadri Sriprasad1.   

Abstract

OBJECTIVES: To analyse and compare data from the British Association of Urological Surgeons Nephrectomy Audit for perioperative outcomes of partial (PN) and radical nephrectomy (RN) for T1 renal tumours. PATIENTS AND METHODS: UK consultants were invited to submit data on all patients undergoing nephrectomy between 1 January and 31 December 2012 to a nationally established database using a standard pro forma. Analysis was made on patient demographics, operative technique, and perioperative data/outcome between PN and RN for T1 tumours.
RESULTS: Overall, data from 6 042 nephrectomies were reported of which 1 768 were performed for T1 renal tumours. Of these, 1 082 (61.2%) were RNs and 686 (38.8%) were PNs. The mean age of patients undergoing PN was lower (PN 59 years vs RN 64 years; P < 0.001) and so was the WHO performance score (PN 0.4 vs RN 0.7; P < 0.001). PN for the treatment of T1a tumours (≤4 cm) accounted for 55.6% of procedures, of which 43.9% were performed using a minimally invasive technique. For T1b tumours (4-7 cm), 18.9% of patients underwent PN, in 33.3% of which a minimally invasive technique was adopted. The vast majority of RNs for T1 tumours were performed using a minimally invasive technique (90.3%). Of the laparoscopic PNs, 30.5% were robot-assisted. There was no significant difference in overall intraoperative complications between the RN and PN groups (4% vs 4.3%; P = 0.79). However, PN accounted for a higher overall postoperative complications rate (RN 11.3% vs PN 17.6%; P < 0.001). RN was associated with a markedly reduced risk of severe surgical complications (Clavien Dindo classification grade ≥3) compared with PN even after adjusting for technique (odds ratio 0.30; P = 0.002). Operation time between RN and PN was comparable (141 vs 145 min; P = 0.25). Blood loss was less in the RN group (mean for RN 165 vs PN 323 mL; P < 0.001); however, transfusion rates were similar (3.2% vs 2.6%; P = 0.47). RN was associated with a shorter length of stay (median 4 vs 5 days; P < 0.001). A direct comparison between robot-assisted and laparoscopic PN showed no significant differences in operation time, blood loss, warm ischaemia time, and intraoperative and postoperative complications.
CONCLUSIONS: PN was the method of choice for treatment of T1a tumours whereas RN was preferred for T1b tumours. Minimally invasive techniques have been widely adopted for RN but not for PN. Despite the advances in surgical technique, a substantial risk of postoperative complications remains with PN.
© 2015 The Authors BJU International © 2015 BJU International Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  BAUS; audit; outcomes; partial nephrectomy; perioperative; radical nephrectomy

Mesh:

Year:  2015        PMID: 25754386     DOI: 10.1111/bju.13114

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  16 in total

1.  The use of intraoperative cell salvage in urologic oncology.

Authors:  Matthew C Ferroni; Andres F Correa; Timothy D Lyon; Benjamin J Davies; Michael C Ost
Journal:  Rev Urol       Date:  2017

Review 2.  Non-Surgical Ablative Therapy for Management of Small Renal Masses-Current Status and Future Trends.

Authors:  K Farrag; S Sriprasad
Journal:  Indian J Surg Oncol       Date:  2016-12-15

Review 3.  Surgical and Minimally Invasive Therapies for the Management of the Small Renal Mass.

Authors:  John Withington; Joana B Neves; Ravi Barod
Journal:  Curr Urol Rep       Date:  2017-08       Impact factor: 3.092

4.  Partial vs Radical Nephrectomy for T1-T2 Renal Masses in the Elderly: Comparison of Complications, Renal Function, and Oncologic Outcomes.

Authors:  Julie Y An; Mark W Ball; Michael A Gorin; Jiwon J Hong; Michael H Johnson; Christian P Pavlovich; Mohamad E Allaf; Phillip M Pierorazio
Journal:  Urology       Date:  2016-11-23       Impact factor: 2.649

5.  The value of a 1-day multidisciplinary robot surgery training for novice robot surgeons.

Authors:  Alexander J W Beulens; Willem M Brinkman; Petra J Porte; Richard P Meijer; Jeroen J G van Merriënboer; Henk G Van der Poel; Cordula Wagner
Journal:  J Robot Surg       Date:  2018-11-22

6.  Tumor complexity and the impact on MIC and trifecta in robot-assisted partial nephrectomy: a multi-center study of over 500 cases.

Authors:  Burkhard Ubrig; Alexander Roosen; Christian Wagner; Guenter Trabs; Frank Schiefelbein; Jorn H Witt; Georg Schoen; Nina Natascha Harke
Journal:  World J Urol       Date:  2018-01-29       Impact factor: 4.226

7.  Platelet to white blood cell ratio predicts 30-day postoperative infectious complications in patients undergoing radical nephrectomy for renal malignancy.

Authors:  Alaina Garbens; Christopher J D Wallis; Georg Bjarnason; Girish S Kulkarni; Avery B Nathens; Robert K Nam; Raj Satkunasivam
Journal:  Can Urol Assoc J       Date:  2017-11       Impact factor: 1.862

8.  Survival benefit of nephron-sparing surgery for patients with pT1b renal cell carcinoma: A population-based study.

Authors:  Xiaode Liu; Xuemei Huang; Pan Zhao; Peng Zhang
Journal:  Oncol Lett       Date:  2019-11-07       Impact factor: 2.967

9.  Partial nephrectomy for T3aN0M0 renal cell carcinoma: shall we step forward?

Authors:  Ding Peng; Zhi-Song He; Xue-Song Li; Qi Tang; Lei Zhang; Kai-Wei Yang; Xiao-Teng Yu; Cui-Jian Zhang; Li-Qun Zhou
Journal:  Int Braz J Urol       Date:  2017 Sep-Oct       Impact factor: 1.541

10.  Small renal masses in Latin-American population: characteristics and prognostic factors for survival, recurrence and metastasis - a multi-institutional study from LARCG database.

Authors:  Thiago Camelo Mourão; Diego Abreu; Gustavo F Carvalhal; Guillermo Gueglio; Walter H da Costa; Vinicius Fernando Calsavara; Luis Meza-Montoya; Rubén G Bengió; Carlos Scorticati; Ricardo Castillejos-Molina; Francisco Rodríguez-Covarrubias; Ana María Autran-Gómez; José Gadu Campos-Salcedo; Alejandro Nolazco; Carlos Ameri; Hamilton Zampolli; Raúl Langenhin; Diego Muguruza; Marcos Tobias Machado; Pablo Mingote; Jorge Clavijo; Lucas Nogueira; Omar Clark; Agustín R Rovegno; Fernando P Secin; Ricardo Decia; Gustavo C Guimarães; Sidney Glina; Oscar Rodríguez-Faba; Joan Palou; Stenio C Zequi
Journal:  BMC Urol       Date:  2020-07-02       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.